×

Dr. Santhosh Kumar K N

Dr. Santhosh Kumar K N

Dr. Santhosh Kumar K N

QualificationMBBS (BMCRI), MD (Medicine, AIIMS Delhi), DM (Medical Oncology, AIIMS Delhi)

SpecialitiesMedical Oncology

Locations HCG Cancer Center - KR BLR
Experience6 years
Book an Appointment

Introduction

Dr. Santhosh Kumar KN is an AIIMS- trained medical oncologist with over 6 years of experience. He had his undergraduate training from Bangalore medical college and Research Institute. Having completed his MD in Medicine and DM in Medical Oncology from the premier central institute AIIMS, New Delhi, he has specialized training in managing a wide range of cancers through systemic therapies, such as chemotherapy, targeted therapy,  immunotherapy and bone marrow transplantation.

He also has experience in devising personalized, multimodal treatment plans for adult and paediatric cancer patients with a specialized focus on their quality of life and overall well-being.

Area of Expertise

Dr. Santhosh Kumar KN is an AIIMS- trained medical oncologist with over 6 years of experience. He had his undergraduate training from Bangalore medical college and Research Institute. Having completed his MD in Medicine and DM in Medical Oncology from the premier central institute AIIMS, New Delhi, he has specialized training in managing a wide range of cancers through systemic therapies, such as chemotherapy, targeted therapy,  immunotherapy and bone marrow transplantation.

He also has experience in devising personalized, multimodal treatment plans for adult and paediatric cancer patients with a specialized focus on their quality of life and overall well-being.

Research & Publications

Research

●       Extended Aprepitant in control of delayed emesis among adults undergoing induction chemotherapy for acute myeloid leukemia—EACODE AML Multicenter phase 3 RCT, Centre

●       Extended Aprepitant in control of delayed emesis among children undergoing induction chemotherapy for acute myeloid leukemia (EACODE-pediatric AML) (Ongoing trial)—Multicenter phase 3 RCT,

●       Retrospective studies and systematic reviews

●       Early stoppage of empirical antibiotic therapy at clinical improvement in pediatric leukemia patients with high-risk febrile neutropenia (ESAT-HR-FN study): Study protocol of a single-center investigator-initiated randomized open-label non-inferiority trial. Heliyon. 2024 Aug 13;10(16):e36310.

 

Awards & Accolades

Dr kumar is an active member of national/international medical organisations

●       European Society of Medical Oncology

●       American Society of Clinical Oncology

●       Indian Society of Medical and Pediatric Oncology

●       Indian Society of Bone Marrow Transplantation

●       Mumbai Hematology Group

Other Doctors

WhatsApp Icon
Google Playstore Download logo
App Store Download logo